ArticleAntimicrobial agents and chemotherapy2020
Clinical Predictive Model of Multidrug Resistance in Neutropenic Cancer Patients with Bloodstream Infection Due to Pseudomonas aeruginosa.
Abstract readMulticenter Study
In one paragraph
Article in Antimicrobial agents and chemotherapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 3 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 3 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Risk factors for colonisation and infection with multidrug-resistant Pseudomonas aeruginosa in intensive care unit: a systematic review and meta-analysis.Systematic reviews · 2026Pooled it
- Clinical epidemiology and case fatality due to antimicrobial resistance in Germany: a systematic review and meta-analysis, 1 January 2010 to 31 December 2021.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2023Pooled it
- Clinical outcomes of antimicrobial resistance in cancer patients: a systematic review of multivariable models.BMC infectious diseases · 2023Pooled it
- Enhanced detection of sepsis pathogens in hospitalized febrile neutropenia patients using blood culture broths with TaqMan array card.Research square · 2026Article
- The epidemiological landscape of bloodstream infections in children undergoing chemotherapy or haematopoietic cell transplantation: A retrospective study by Infectious Diseases Working Group of Italian Association of Pediatric Hematology and Oncology (AIEOP).British journal of haematology · 2025Article
- Gram-negative bacterial bloodstream infections in cancer patients: a study of epidemiological trends and antibiotic susceptibility.Tropical medicine and health · 2025Article
- Can We Lower the Burden of Antimicrobial Resistance (AMR) in Heavily Immunocompromised Patients? A Narrative Review and Call to Action.Infectious diseases and therapy · 2025Review
- Article
- The double-edged sword: impact of antibiotic use on immunotherapy efficacy in advanced hepatocellular carcinoma.BMC gastroenterology · 2025Article
- Risk factors for detection of Pseudomonas aeruginosa in clinical samples upon hospital admission.Antimicrobial resistance and infection control · 2025Article
- Molecular epidemiology and antimicrobial resistance profiles ofFrontiers in microbiology · 2025Article
- Expanding subcutaneous mass on the scalp of an immunocompromised woman.Skin health and disease · 2024Article
- Patterns of fluoroquinolone utilization and resistance in a tertiary care hospital: a retrospective cross-sectional analysis study from a developing country.BMC infectious diseases · 2024Article
- Article
- Species Distribution, Typical Clinical Features and Risk Factors for Poor Prognosis of Super-Elderly Patients with Bloodstream Infection in China.Infection and drug resistance · 2024Article
- The Etiology, Antibiotic Therapy and Outcomes of Bacteremic Skin and Soft-Tissue Infections in Onco-Hematological Patients.Antibiotics (Basel, Switzerland) · 2023Article
- Review
- Immunization with lytic polysaccharide monooxygenase CbpD induces protective immunity againstProceedings of the National Academy of Sciences of the United States of America · 2023Article
- Levofloxacin prophylaxis vs no prophylaxis in patients with neutropenia within an endemic country for carbapenem-resistant GNB.Blood advances · 2023Article
- Antibiogram of Multidrug-Resistant Bacteria Based on Sepsis Onset Location in Korea: A Multicenter Cohort Study.Journal of Korean medical science · 2023Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
40 authors.
C GudiolInfectious Diseases Department, Bellvitge University Hospital, IDIBELL, University of Barcelona, Barcelona, Spain cgudiol@iconcologia.net jcarratala@bellvitgehospital.cat.ORCID 0000-0003-3095-4422
A Albasanz-PuigInfectious Diseases Department, Bellvitge University Hospital, IDIBELL, University of Barcelona, Barcelona, Spain.
J Laporte-AmargósInfectious Diseases Department, Bellvitge University Hospital, IDIBELL, University of Barcelona, Barcelona, Spain.
N PallarèsStatistics Advisory Service, Institute of Biomedical Research of Bellvitge, Barcelona, Spain.
A MussettiHaematology Department, Institut Català d'Oncologia (ICO)-Hospital Duran i Reynals, IDIBELL, Barcelona, Spain.
I Ruiz-CampsInfectious Diseases Department, Vall d'Hebron University Hospital, Barcelona, Spain.
P Puerta-AlcaldeInfectious Diseases Department, Hospital Clínic i Provincial, Barcelona, Spain.
E AbdalaInstituto do Câncer do Estado de São Paulo, Faculty of Medicine, University of São Paulo, São Paulo, Brazil.
C OltoliniUnit of Infectious and Tropical Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.
M AkovaDepartment of Infectious Diseases, Hacettepe University School of Medicine, Ankara, Turkey.
M MontejoInfectious Diseases Unit, Cruces University Hospital, Bilbao, Spain.
M MikulskaDivision of Infectious Diseases, University of Genoa (DISSAL) and Ospedale Policlinico San Martino, Genoa, Italy.
P Martín-DávilaInfectious Diseases Department, Ramon y Cajal Hospital, Madrid, Spain.
F HerreraInfectious Diseases Section, Department of Medicine, Centro de Educación Médica e Investigaciones Clínicas (CEMIC), Buenos Aires, Argentina.
O GaschInfectious Diseases Department, Parc Taulí University Hospital, Sabadell, Spain.
L DrgonaOncohematology Department, Comenius University and National Cancer Institute, Bratislava, Slovakia.
H Paz MoralesInfectious Diseases Department, Hospital Erasto Gaertner, Curitiba, Brazil.
A-S BrunelInfectious Diseases Department, Department of Medicine, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
E GarcíaHaematology Department, Reina Sofía University Hospital-IMIBIC-UCO, Córdoba, Spain.
B IslerDepartment of Infectious Diseases and Clinical Microbiology, Istanbul Education and Research Hospital, Istanbul, Turkey.
W V KernDivision of Infectious Diseases, Department of Medicine II, University of Freiburg Medical Center and Faculty of Medicine, Freiburg, Germany.
I MoralesEmergency Clinical Unit and Infectious Diseases Division, Hospital Universitario Virgen Macarena, Seville, Spain.
G Maestro-de la CalleInfectious Diseases Unit, Instituto de Investigación Hospital 12 de Octubre (i+12), 12 de Octubre University Hospital, School of Medicine, Universidad Complutense, Madrid, Spain.
M MonteroInfectious Diseases Service, Hospital del Mar, Infectious Pathology and Antimicrobials Research Group (IPAR), Institut Hospital del Mar d'Investigations Mèdiques (IMIM), Universitat Autònoma de Barcelona (UAB), CEXS-Universitat Pompeu Fabra, Barcelona, Spain.
S S KanjInfectious Diseases Division, American University of Beirut Medical Center, Beirut, Lebanon.
O R SipahiEge University Faculty of Medicine, Izmir, Turkey.
S CalikUniversity of Health Science Izmir Bozyaka Training and Research Hospital, Izmir, Turkey.
I Márquez-GómezInfectious Diseases Department, Hospital Regional de Málaga, Málaga, Spain.
J I MarinInfectious Diseases and Clinical Microbiology Department, Clínica Maraya, Pereira, Colombia.
M Z R GomesHospital Federal dos Servidores do Estado and Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Ministério da Saúde, Rio de Janeiro, Brazil.ORCID 0000-0001-6492-1034
P HemmattiDepartment of Hematology, Oncology and Palliative Care, Klinikum Ernst von Bergmann, Academic Teaching Hospital of Charité University Medical School, Berlin, Germany.
R AraosInstituto de Ciencias e Innovación en Medicina, Facultad de Medicina Clínica Alemana, Universidad del Desarrollo, Santiago de Chile, Chile.
M PeghinInfectious Diseases Clinic, Department of Medicine, University of Udine and Azienda Sanitaria Universitaria Integrata, Udine, Italy.
J L Del PozoInfectious Diseases and Microbiology Unit, Navarra University Clinic, Pamplona, Spain.
L YáñezHaematology Department, Marqués de Valdecilla University Hospital, Santander, Spain.
R TilleyMicrobiology Department, University Hospitals Plymouth NHS Trust, Plymouth, United Kingdom.
A ManzurInfectious Diseases, Hospital Rawson, San Juan, Argentina.
A NovoHaematology Department, Son Espases University Hospital, Palma de Mallorca, Spain.
J CarratalàInfectious Diseases Department, Bellvitge University Hospital, IDIBELL, University of Barcelona, Barcelona, Spain cgudiol@iconcologia.net jcarratala@bellvitgehospital.cat.
IRONIC Study Group
Funding
No grant is acknowledged in the PubMed record.
Abstract
We aimed to assess the rate and predictive factors of bloodstream infection (BSI) due to multidrug-resistant (MDR)
Indexed as
Drug Resistance, Multiple, BacterialAnti-Bacterial AgentsBacteremiaFemaleHumansMaleMicrobial Sensitivity TestsMiddle AgedModels, BiologicalNeoplasmsNeutropeniaPseudomonas aeruginosaPseudomonas InfectionsRetrospective StudiesRisk FactorsROC CurveAnti-Bacterial Agentsbacteremiabloodstream infectioncancermultidrug resistantneutropeniapredictive modelPseudomonas aeruginosarisk factors
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.